•   
  •   

UK News Private equity sharks circle GlaxoSmithKline's consumer arm

02:43  13 october  2021
02:43  13 october  2021 Source:   dailymail.co.uk

George Horne stresses the need for Glasgow Warriors to turn it on for the full 80 minutes

  George Horne stresses the need for Glasgow Warriors to turn it on for the full 80 minutes For 50 minutes it was pretty much the perfect Glasgow Warriors performance but George Horne knows they will need to turn it on for the full 80 if they are to challenge at the business end of the United Rugby Championship this season. © Scrum-half George Horne helped Glasgow to a 35-24 win over the Sharks. Picture: Craig Williamson/SNS The scrum-half was a lively presence as the home team scored five tries in a 35-24 victory over a Sharks side caught cold by Glasgow’s speed and intensity.It was their first competitive fixture in front of fans at Scotstoun since February 2020 and Horne said the players fed off the atmosphere.

GlaxoSmithKline Plc’ s consumer unit is drawing interest from private equity firms as the pharma giant prepares to split off the business, people with knowledge of the matter said. The London-listed drugmaker’ s advisers are informally fielding interest in the operations alongside preparations for a listing, the people said, asking not to be identified because the information is private . Advent International, Blackstone Inc., Carlyle Group Inc., CVC Capital Partners, KKR & Co. and Permira are among potential suitors evaluating the business, according to the people.

– GlaxoSmithKline ’ s consumer healthcare unit is drawing interest from private equity firms such as Advent, CVC and KKR, ahead of the British drugmaker’s planned separation next year, Bloomberg News reported on Tuesday, citing sources.

MailOnline logo © Provided by This Is Money MailOnline logo

Private equity groups are plotting a swoop on the consumer arm of Glaxosmithkline in what could be the biggest takeover by the buyout industry in history.

The circling predators have valued the pharma giant's consumer business, which owns brands including Aquafresh toothpaste and Otrivin nasal spray and is being spun out of GSK by chief executive Emma Walmsley, at £40billion or more.

Walmsley's plan is to list the consumer healthcare arm as a separate entity on the stock market in London with annual sales of more than £10billion.

( © Provided by This Is Money (

But if a sale is agreed instead, it would be the biggest private equity takeover on record, surpassing the £33billion buyout of US energy giant TXU in 2007 by KKR and TPG.

Morrisons faces petrol station probe ahead of £7bn takeover deal vote

  Morrisons faces petrol station probe ahead of £7bn takeover deal vote Morrisons chief exec David Potts (pictured) could make £22m from the proposed £7bn takeover. Regulators are concerned about the number of petrol stations the group would own. Officials at the Competition and Markets Authority are monitoring the situation after Clayton, Dubilier & Rice beat rival Fortress in a bidding war over the weekend.In a rare auction that gripped the City, CD&R tabled a winning bid of 287p a share, which valued the supermarket at £7billion and topped the Fortress offer of 286p. © Provided by This Is Money ( Shares fell 3.7 per cent, or 11.1p, to 285.

GlaxoSmithKline Plc’ s consumer unit is drawing interest from private equity firms in what could lead to the biggest buyout of all time, people with knowledge of the matter said. The London-listed drugmaker’ s advisers are informally fielding interest in the operations alongside preparations for a listing, the people said, asking not to be identified because the information is private . Advent International, Blackstone Inc., Carlyle Group Inc., CVC Capital Partners, KKR & Co. and Permira are among potential suitors evaluating the business, according to the people. The consumer unit could

GlaxoSmithKline ' s consumer healthcare unit is drawing interest from private equity firms such as Advent, CVC and KKR, ahead of the British drugmaker's planned separation next year, Bloomberg News reported on Tuesday, citing sources. (Reporting by Pushkala Aripaka in Bengaluru

GSK is just the latest British firm to attract interest from private equity predators which have targeted several household names during the Covid-19 pandemic.

Companies that have found themselves in the crosshairs include supermarkets Morrisons and Asda, and security firm G4S, as well as British defence industry stalwarts Ultra Electronics and Meggitt.

The influx of private equity bargain hunters has sparked an outcry across the political spectrum amid worries the spate of takeovers is hollowing out British industry, loading firms up with debt, and leaving crucial technologies in foreign hands.

News of the potential GSK swoop drew swift condemnation from Tory grandee Lord Heseltine last night, who said the ongoing ravaging of UK industry by private equity firms showed 'an opting out of British control in a way that is unlike international practice'.

10 of the easiest cars to park in busy cities

  10 of the easiest cars to park in busy cities The best cars for people who can't park. Discover which motors are considered some of the easiest to park in a busy city and the cars easiest to park in small spaces.We've chosen 10 new cars that tick all the right boxes for city dwellers. If you are tempted, many of the recommended models also come with parking sensors and reversing cameras to make parking even easier when space is the issue.

GlaxoSmithKline Plc’ s consumer unit is drawing interest from private equity firms in what could lead to the biggest buyout of all time, people with knowledge of the matter said. The London-listed drugmaker’ s advisers are informally fielding interest in the operations alongside preparations for a The consumer unit could also attract some of the world’ s biggest pharmaceutical and consumer goods companies, the people said. The unit could be valued at 40 billion pounds ( billion) or more in any deal, the people said. Shares in Glaxo rose as much as 4.8% in London trading Tuesday.

* private equity firms circle glaxosmithkline ’ s billion consumer arm - bloomberg news. * potential suitors for glaxosmithkline ’ s billion consumer arm include advent, CVC, KKR - bloomberg news. * BLACKSTONE INC, CARLYLE GROUP, PERMIRA ALSO AMONG POTENTIAL SUITORS EVALUATING GSK ’ S CONSUMER ARM - BLOOMBERG NEWS Further company coverage

He said: 'Britain has become a job-lot economy, there is no strategic assessment like in America, Germany, France and other countries.

'There is a worrying aspect of this whole process that the people who make the recommendations are more incentivised to accept.'

Lord Sikka, professor of accounting at the University of Essex, said private equity firms are 'not really interested in the long-term business', adding: 'It's all about increasing returns and one aspect of that is loading entities with debt and the second is you butcher them up.'

Several private equity outfits including Advent International, CVC Capital Partners and KKR are said to be sniffing around for any deal that could see the GSK consumer business fall into their hands, according to Bloomberg.

And activist investors ramped up the pressure on GSK's board this week. Bluebell Capital called on chairman Jonathan Symonds to quit, having previously joined US hedge fund Elliott in demanding Walmsley reapply for her own job.

Read more

Grammys release inclusion requirement to ensure diverse show .
The Duchess of Cambridge, Kate Middleton, is surprised by Ant and Dec at an addiction awareness event.

usr: 8
This is interesting!